Emergent BioSolutions Reports FDA Advisory Committees’
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription
Globe Newswire16-02-2023, 05:26
Nyxoah Strengthens its Executive Leadership Team 29-11-2023, 04:30